MAXZIDE
Live / Registered — Registered and renewed (as of 12 Mar 2026)
What this means for you
Registered since 07 Jan 1986. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Jan 2026).
Record
- Serial number
- 73483161
- Registration number
- 1376817
- Mark type
- Design + words
- Filed
- 01 Jun 1984
- Published for opposition
- 25 Jun 1985
- Registered
- 07 Jan 1986
- Next maintenance due
- 07 Jan 2026
- Attorney of record
- Lynn E. Rzonca
Goods and services
- Class 005 — Pharmaceuticals: ANTI-HYPERTENSIVE MEDICATION
Owner
- AUROBINDO PHARMA LIMITED, AMEERPET HYDERABAD, IN
- MYLAN PHARMACEUTICALS, INC., MORGANTOWN, WV, US
- AMERICAN CYANAMID COMPANY, WAYNE, NJ, US
- AMERICAN CYANAMID COMPANY, WAYNE, NJ, US
- AMERICAN CYANAMID COMPANY, WAYNE, NJ, US
Prosecution history
- 12 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Mar 2026 — REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
- 12 Mar 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 11 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Dec 2025 — TEAS SECTION 8 & 9 RECEIVED
- 07 Jan 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 20 Sept 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 May 2016 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 04 Mar 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 04 Mar 2016 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 04 Mar 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 17 Dec 2015 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 02 Mar 2016 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 02 Mar 2016 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 01 Mar 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL